Technology

Patient Population

Root & Ascending Aortic Diseases

The Veritas Transcatheter Valved Aortic Root Conduit (TVARC) is designed to treat patients with high-risk pathologies involving the aortic root, coronary ostia and/or the ascending aorta, where conventional surgical intervention may present elevated risk or significant procedural complexity. The system is engineered to support minimally invasive treatment of ascending aortic pathology while maintaining procedural precision, conformability, and long-term hemodynamic performance.

The target patient population may include individuals with:

  • Ascending Aortic Dissections

  • Intramural Hematoma (IMH)

  • Penetrating Atherosclerotic Ulcer (PAU)

  • Ascending Aortic Aneurysms

Veritas Transcatheter Valved Aortic Root Conduit (TVARC)

Engineered to address the anatomical and hemodynamic challenges of the proximal aorta, the system combines precision deployment, conformability, and durable performance within a fully integrated transcatheter platform.

Built to support treatment of pathologies originating from the aortic valve to ascending aorta, the platform is intended for patients with Type A Ascending Aortic Dissections, Intramural Hematoma (IMH), Penetrating Atherosclerotic Ulcer (PAU), and Ascending Aortic Aneurysms.

The single implant platform integrates:

  • Bioprosthetic valve

  • Ascending aortic conduit

  • Proprietary Chameleon Eye™ coronary perfusion technology

Featuring a low profile delivery system, controlled deployment, and modular architecture, the platform is designed to support procedural precision, physician confidence, and reliable long-term performance across a wide range of patient anatomies.